N-terminal modifications leading to peptide ORL1 partial agonists and antagonists.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Journal of Peptide Research

• Publication date

  2003-11-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1034/J.1399-3011.2003.00077.XPMID 14531842
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Nphe1,Arg14,Lys15]Nociceptin‐NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor

  2002cited by this paper
• Pharmacological profiles of a novel opioid receptor‐like1 (ORL1) receptor antagonist, JTC‐801

  2002cited by this paper
• High-affinity, non-peptide agonists for the ORL1 (orphanin FQ/nociceptin) receptor.

  2000cited by this paper
• A synthetic agonist at the orphanin FQ/nociceptin receptor ORL1: anxiolytic profile in the rat.

  2000cited by this paper
• Pharmacology of nociceptin and its receptor: a novel therapeutic target

  2000cited by this paper
• Species differences in the efficacy of compounds at the nociceptin receptor (ORL1).

  2000cited by this paper
• In vitro and in vivo pharmacological characterization of J-113397, a potent and selective non-peptidyl ORL1 receptor antagonist.

  2000cited by this paper
• Characterization of [Nphe1]nociceptin(1‐13)NH2, a new selective nociceptin receptor antagonist

  2000cited by this paper
• The opioid-receptor-like 1 (ORL-1) as a potential target for new analgesics.

  2000cited by this paper
• Inhibition of cardiovascular activity following microinjection of novel opioid-like neuropeptide nociceptin (orphanin FQ) into the rat rostral ventrolateral medulla.

  1999cited by this paper
• Discovery of the first potent and selective small molecule opioid receptor-like (ORL1) antagonist: 1-[(3R,4R)-1-cyclooctylmethyl-3- hydroxymethyl-4-piperidyl]-3-ethyl-1, 3-dihydro-2H-benzimidazol-2-one (J-113397).

  1999cited by this paper
• Antagonism by acetyl‐RYYRIK‐NH2 of G protein activation in rat brain preparations and of chronotropic effect on rat cardiomyocytes evoked by nociceptin/orphanin FQ

  1999cited by this paper
• A new selective antagonist of the nociceptin receptor

  1998cited by this paper
• [Phe1psi(CH2-NH)Gly2]nociceptin-(1-13)-NH2 acts as an agonist of the orphanin FQ/nociceptin receptor in vivo.

  1998cited by this paper
• ORL‐1 and Mu opioid receptor antisera label different fibers in areas involved in pain processing

  1998cited by this paper
• [Phe1psi(CH2-NH)Gly2]nociceptin-(1-13)-NH2 is an agonist of the nociceptin (ORL1) receptor.

  1998cited by this paper
• Pharmacological characterization of the nociceptin receptor mediating hyperalgesia in the mouse tail withdrawal assay

  1998cited by this paper
• Binding and in vitro activities of peptides with high affinity for the nociceptin/orphanin FQ receptor, ORL1.

  1997cited by this paper
• Analgesic effect of intrathecally administered nociceptin, an opioid receptor-like1 receptor agonist, in the rat formalin test.

  1997cited by this paper
• Bidirectional modulatory effect of orphanin FQ on morphine‐induced analgesia: antagonism in brain and potentiation in spinal cord of the rat

  1997cited by this paper
• Relationship between binding affinity and functional activity of nociceptin/orphanin FQ.

  1997cited by this paper
• Recognition and activation of the opioid receptor-like ORL 1 receptor by nociceptin, nociceptin analogs and opioids.

  1997cited by this paper
• Functional antagonism of μ-, δ- and κ-opioid antinociception by orphanin FQ

  1996cited by this paper
• Nociceptin receptor coupling to a potassium conductance in rat locus coeruleus neurones in vitro

  1996cited by this paper
• Modulation of Voltage-Gated Calcium Channels by Orphanin FQ in Freshly Dissociated Hippocampal Neurons

  1996cited by this paper
• Sensitivity of Opioid Receptor-like Receptor ORL1 for Chemical Modification on Nociceptin, a Naturally Occurring Nociceptive Peptide*

  1996cited by this paper
• Structure-Activity Relationship Studies on the Novel Neuropeptide Orphanin FQ*

  1996cited by this paper
• Immunohistochemical localization of ORL‐1 in the central nervous system of the rat

  1996cited by this paper
• Orphanin FQ: receptor binding and analog structure activity relationships in rat brain.

  1996cited by this paper
• Functional selectivity of orphanin FQ for its receptor coexpressed with potassium channel subunits in Xenopus laevis oocytes.

  1996cited by this paper
• Functional antagonism of mu-, delta- and kappa-opioid antinociception by orphanin FQ.

  1996cited by this paper
• Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor

  1995cited by this paper
• Orphanin FQ: A Neuropeptide That Activates an Opioidlike G Protein-Coupled Receptor

  1995cited by this paper
• Modulation by mu-opioid agonists of guanosine-5'-O-(3-[35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells.

  1995cited by this paper
• Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

  1973cited by this paper

• The life and times of endogenous opioid peptides: Updated understanding of synthesis, spatiotemporal dynamics, and the clinical impact in alcohol use disorder

  2022cites this paper
• NOP-Targeted Peptide Ligands.

  2019cites this paper
• Medicinal Chemistry, Pharmacology, and Biological Actions of Peptide Ligands Selective for the Nociceptin/Orphanin FQ Receptor

  2013cites this paper
• UFP‐112 a Potent and Long‐Lasting Agonist Selective for the Nociceptin/Orphanin FQ Receptor

  2011cites this paper
• Development of nociceptin receptor (NOP) agonists and antagonists

  2011cites this paper
• Nociceptin/orphanin FQ - NOP receptor system: novel genetic and pharmacological tools

  2011cites this paper
• Nociceptin/orphanin FQ receptor ligands : pharmacological studies

  2009cites this paper
• Formation of Multiple Dimer Interfaces in the Active and Inactive States of a Model G Protein-Coupled Receptor

  2009influential citation
• Tryptophan replacement in the nociceptin/orphanin FQ receptor ligand Ac-RYYRWK-NH2.

  2008cites this paper
• Designed modification of partial agonist of ORL1 nociceptin receptor for conversion into highly potent antagonist.

  2008cites this paper
• Anti-nociceptive and anti-allodynic effects of a high affinity NOP hexapeptide [Ac-RY(3-Cl)YRWR-NH2] (Syn 1020) in rodents.

  2007cites this paper
• Opioid receptor‐like 1 (ORL1) receptor binding and the biological properties of Ac‐Arg‐Tyr‐Tyr‐Arg‐Ile‐Arg‐NH2 and its analogs

  2007cites this paper
• In vitro and in vivo pharmacological characterization of the nociceptin/orphanin FQ receptor ligand Ac-RYYRIK-ol.

  2006cites this paper
• Biochemical, functional and pharmacological characterization of novel hexapeptide ligands targeting nociceptin/orphanin FQ receptor, in vitro and in vivo studies

  2006cites this paper
• In vitro Binding and Functional Studies of Ac-RYYRIK-ol and Its Derivatives, Novel Partial Agonists of the Nociceptin/Orphanin F/Q Receptor

  2006cites this paper
• Emerging analgesics in cancer pain management

  2005cites this paper
• Endogenous opiates and behavior: 2003.

  2004cites this paper
• Nociceptin antagonism: probing the receptor by N-acetyl oligopeptides.

  2004cites this paper
• Ligand-regulated internalization of the opioid receptor-like 1: a confocal study.

  2004cites this paper
• The design and synthesis of a novel quinolizidine template for potent opioid and opioid receptor-like (ORL1, NOP) receptor ligands.

  2004cites this paper
• Structure-activity studies on high affinity NOP-active hexapeptides.

  2004cites this paper